Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

Revealing its true strength

Article Abstract:

Ferraris has a strong medical and components division and this is not apparent from the company's interim results to Feb 1998. The company's engineering operation in eastern Germany is also performing well. Warren E. Collins, a US acquisition, could help the company to market its products directly in the US. The German actuators operation is also performing well in the US. Ferraris' profit is forecast at 2.3 million pounds sterling for 1997 to 1998 by Henderson Crosthwaite.

Publisher: FT Business
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1998
Ferraris

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Graseby

Article Abstract:

Graseby has acquired 3MIT from 3M, which gives the company a sales force in the US that can sell Graseby products such as ambulatory pumps. 3MIT is involved in delivery syringe pumps. Graseby's environmental division has reduced its costs and increased its profit, as has the technology division. The company's profit is forecast at 93 million pounds sterling by brokers for full year 1996 compared with 6 million pounds for the previous year.

Publisher: FT Business
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1996
Graseby PLC

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: Management, Medical equipment, Medical equipment and supplies industry, Medical equipment industry
Similar abstracts:
  • Abstracts: Investing in the future. Division: a new dawn. Delcam
  • Abstracts: Heading back up. Bass. Belhaven Brewery
  • Abstracts: Investing in food stocks. Food
  • Abstracts: Creo Products Inc. (CREO). Network Engines, Inc. (NENG). TriZetto Group, Inc. (TZIX)
  • Abstracts: Energy out of fizz. Duke Energy Corporation. Aggreko in the spotlight
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2023 Advameg, Inc.